New Key Statistics Module, Z-Score and F-Score
NAS:CTSO Key Ratios
| Market Cap $ M | 47.79 |
| Enterprise Value $ M | 51.97 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 2.05 |
| Price/Sales | 1.26 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 31.00 |
| EPS (TTM) $ | -0.64 |
| Beneish M-Score | -3.33 |
| 10-y EBITDA Growth Rate % | -3.10 |
| 5-y EBITDA Growth Rate % | -7.00 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -1.67 |
| EV-to-EBITDA | -1.78 |
| PEG | -- |
| Shares Outstanding M | 54.31 |
| Net Margin (%) | -91.71 |
| Operating Margin % | -100.19 |
| Pre-tax Margin (%) | -94.33 |
| Quick Ratio | 1.51 |
| Current Ratio | 1.77 |
| ROA % (ttm) | -52.03 |
| ROE % (ttm) | -109.47 |
| ROIC % (ttm) | -99.24 |
| Dividend Yield % | -- |
| Altman Z-Score | -7.44 |
CTSO Number of Guru Trades
CTSO Volume of Guru Trades
Gurus Latest Trades with NAS:CTSO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:CTSO is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
CytoSorbents Corp Insider Transactions
No Available Data
News about NAS:CTSO
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers